Fred Eshelman is an angel investor and operator angel based in Wilmington, North Carolina, United States. The known portfolio counts 9 companies: G1 Therapeutics, Aruna Biomedical, Kinnate Biopharma, Sapience Therapeutics, Breakthru Medicine, Cellective BioTherapy, Dignify Therapeutics, Furiex Pharmaceuticals and Innocrin Pharmaceuticals.
Is Fred Eshelman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Series A
- Sector
- Healthcare
Contacts
Fred Eshelman portfolio companies (9)
- G1 Therapeutics
- Aruna Biomedical
- Kinnate Biopharma
- Sapience Therapeutics
- Breakthru Medicine
- Cellective BioTherapy
- Dignify Therapeutics
- Furiex Pharmaceuticals
- Innocrin Pharmaceuticals
Investor Profile
The known portfolio sits in sector Healthcare, and focus areas Biotech, MedTech, Pharmaceuticals and Therapeutics.
Fred Eshelman appears in Series A rounds across the known deals.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Similar investors
Showing 20 of 100
Chris Jackson
angel investor and operator angel
New York, United States
David Wiersma
angel investor
Tucson, United States
Barbara Lubash
angel investor
Orange County, United States
William Fairchild
angel investor and operator angel
Encinitas, United States
Franklin Berger
angel investor
New York, United States
Kevin Ferro
angel investor and operator angel
Miami, United States
Daniel Bradbury
angel investor and operator angel
San Diego, United States
Florian Müllershausen
angel investor
Basel, Switzerland
Ted Love
operator angel
Shawn Fu
angel investor and operator angel
San Francisco, United States
Michael Chambers
angel investor and operator angel
Fargo, United States
Eric W. Linsley
angel investor
Durham, United States
Keith Freeman
angel investor
Denver, United States
Jeffrey Kaditz
angel investor
Phillip Frost
Chairman
Miami, United States
Michael Aberman
angel investor
New York, United States
Alfred Scheidegger
angel investor and operator angel
Zürich, Switzerland
Anurag Agarwal
angel investor and operator angel
Philadelphia, United States
Frank Hensel
angel investor
Andrew Sandford
angel investor
Boston, United States
Frequently asked questions
Who is Fred Eshelman?
Fred Eshelman is an angel investor and operator angel based in Wilmington, North Carolina, United States with 9 known investments on file, among them G1 Therapeutics, Aruna Biomedical and Kinnate Biopharma. The sections above list the sectors and stages attached to that record.
What does Fred Eshelman invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, MedTech, Pharmaceuticals and Therapeutics. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Fred Eshelman invest at?
The known deals of Fred Eshelman include Series A rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Fred Eshelman?
A LinkedIn page is on file for Fred Eshelman. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal